TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
Washington, D.C. — On April 19, The House Appropriations Committee approved its budget — at $21.3 billion in funding — for the fiscal year 2017. And in a report that accompanied the spending bill, the committee asked the FDA to extend Freedom of Information Act (FOIA) exemption to certain “checkoff programs” that promote commodities in the agriculture Read More…
A since-deleted analysis posted the agency’s website shows it is relying on unpublished reports from groups linked to biochem industry The U.S. Environmental Protection Agency (EPA) used industry-funded research to conclude that the herbicide chemical glyphosate is not likely to cause cancer in humans—contradicting findings by the World Health Organization (WHO)—according to an analysis the Read More…
Lobbying allows special interest groups to control the way laws are shaped and how healthcare policies are both created and enforced. Pharmaceutical companies are some of the richest, most profitable companies in the world. Besides using profits to advertise products and influence prescription-writing target markets, Pharma spends extraordinary amounts of money on patents to protect Read More…
Confirming that the TransAtlantic Trade and Investment Partnership (TTIP) amounts to “a huge transfer of power from people to big business, “Greenpeace Netherlands on Monday leaked 248 secret pages of the controversial trade deal between the U.S. and EU, exposing how environmental regulations, climate protections, and consumer rights are being “bartered away behind closed doors.” Read More…
In April of 2013, Britain and France informed the United Nations that there was credible evidence that Syria used chemical weapons against rebel forces. Only two months later, in June of 2013, the United States concluded that the Syrian government did, in fact, use chemical weapons in its fight against opposition forces. President Obama immediately Read More…
With the “Affordable Care Act” now fully in place, the middle class is feeling the squeeze yet again through higher insurance costs, making quality health care unaffordable for many. On top of that, pharmaceutical drug prices continue to increase, especially cancer drugs which have skyrocketed. Since 2000, the average monthly cost of oral cancer drugs went from $1,869 per Read More…